Does RISPERIDONE Cause Salivary hypersecretion? 485 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 485 reports of Salivary hypersecretion have been filed in association with RISPERIDONE (Risperidone). This represents 0.6% of all adverse event reports for RISPERIDONE.
485
Reports of Salivary hypersecretion with RISPERIDONE
0.6%
of all RISPERIDONE reports
36
Deaths
246
Hospitalizations
How Dangerous Is Salivary hypersecretion From RISPERIDONE?
Of the 485 reports, 36 (7.4%) resulted in death, 246 (50.7%) required hospitalization, and 22 (4.5%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
Yes, Salivary hypersecretion is listed as a known adverse reaction in the official FDA drug label for RISPERIDONE.
What Other Side Effects Does RISPERIDONE Cause?
Gynaecomastia (24,453)
Off label use (10,376)
Abnormal weight gain (9,418)
Weight increased (6,885)
Emotional disorder (5,809)
Product use in unapproved indication (5,551)
Drug ineffective (5,232)
Injury (4,447)
Hyperprolactinaemia (4,124)
Galactorrhoea (3,513)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
SERTRALINE (163)
Which RISPERIDONE Alternatives Have Lower Salivary hypersecretion Risk?
RISPERIDONE vs RITALIN
RISPERIDONE vs RITLECITINIB
RISPERIDONE vs RITODRINE
RISPERIDONE vs RITONAVIR
RISPERIDONE vs RITUXAN